About Mestastop
Mestastop is a company based in Bengaluru (India) founded in 2018 by Debabani Roy Chowdhury and Arnab Roy Chowdhury. Mestastop has raised $1.29 million across 8 funding rounds from investors including Mumbai Angels, Malpani Ventures and IKP Knowledge Park. Mestastop offers products and services including Drug Discovery Platform, Drug Repurposing Service, and Clinical Translations Tool. Mestastop operates in a competitive market with competitors including GRAIL, Color, Earli, Newcells Biotech and Biovica, among others.
- Headquarter Bengaluru, India
- Founders Debabani Roy Chowdhury, Arnab Roy Chowdhury
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Mestastop Solutions Private Limited
- Date of Incorporation 06 Sep, 2018
- Jurisdiction Bangalore, Karnataka, India
-
Annual Revenue
$20.06 K (USD)29957.82as on Mar 31, 2022
-
Net Profit
-$170.33 K (USD)-14.51as on Mar 31, 2022
-
EBITDA
-$184.67 K (USD)-26.08as on Mar 31, 2022
-
Total Equity Funding
$1.29 M (USD)
in 8 rounds
-
Latest Funding Round
$315.12 K (USD), Grant
Nov 27, 2024
-
Investors
Mumbai Angels
& 27 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Mestastop
Mestastop offers a comprehensive portfolio of products and services, including Drug Discovery Platform, Drug Repurposing Service, and Clinical Translations Tool.
System for identifying novel cancer targets in translational settings
Method to repurpose drugs for delaying cancer metastasis
Machine learning approach for accurate pre-clinical study designs
People of Mestastop
Unlock access to complete
Unlock access to complete
Funding Insights of Mestastop
Mestastop has successfully raised a total of $1.29M across 8 strategic funding rounds. The most recent funding activity was a Grant round of $315.12 thousand completed in November 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Mestastop
Mestastop has secured backing from 28 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Mumbai Angels, Malpani Ventures and IKP Knowledge Park.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Business incubation services are provided across multiple sectors.
|
Locked | Locked | Locked | |
|
Angel network focused on pre-seed & seed-stage startups
|
Locked | Locked | Locked | |
|
Med-tech startups are incubated by IKP Knowledge Park.
|
Locked | Locked | Locked |
Investor details for Mestastop
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Mestastop
Investment portfolio details for Mestastop
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Mestastop
Detailed financials for Mestastop
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Mestastop Comparisons
Peer comparison for Mestastop
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Mestastop
Mestastop operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GRAIL, Color, Earli, Newcells Biotech and Biovica, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Circulating tumor DNA is screened for early cancer detection.
|
|
| Locked | Locked | Locked |
Cancer care is delivered through a virtual clinic by Color.
|
|
| Locked | Locked | Locked |
Early cancer detection tests are developed using synthetic biomarkers.
|
|
| Locked | Locked | Locked |
Induced pluripotent stem cell-derived organoid models are developed for research.
|
|
| Locked | Locked | Locked |
Tumor response to cancer therapies is monitored via specialized assays.
|
|
| Locked | Locked | Locked |
Cell-based assays and 3D microtissues for drug screening are developed.
|
Detailed competitors of Mestastop
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Mestastop
Complete news archive for Mestastop
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mestastop
Mestastop was founded in 2018 and raised its 1st funding round 1 year after it was founded.
Mestastop is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Mestastop is a funded company, having raised a total of $1.29M across 8 funding rounds to date.
Annual revenue of Mestastop is $20.06K as on Mar 31, 2022.
Mestastop was established in 2018 in Bengaluru, India, within the biotechnology sector. Focus is placed on cell-based functional assays for drug discovery and predictive diagnostics targeting cancer metastasis. A platform including Metaassay, Metvivo, and Metscan is employed to evaluate compounds via in vitro tests for metastasis inhibition potential. Lead molecules are advanced through genetically engineered xenograft models to support research progression.
Mestastop's top competitors include GRAIL, Earli and Newcells Biotech.
Mestastop offers Drug Discovery Platform, Drug Repurposing Service, and Clinical Translations Tool.
Mestastop has 28 investors. Key investors include Mumbai Angels, Malpani Ventures, IKP Knowledge Park, Vistari Venture Partners, and BIRAC.
The valuation of Mestastop is $4.75M as of May 2024.